Baseline CD4<sup>+</sup> and expansion of γδ T cells correlate with response to durvalumab in triple-negative breast cancer patients No … ← Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions ISWI catalyzes nucleosome sliding in condensed nucleosome arrays →